Biogen Idec Inc.

Headquarters location: 14 Cambridge Center, Cambridge MA 02142 Tel. 617-679-2000 Job offers, investor relations: www.biogenidec.com Stock:

Biogen Idec belongs to shareholder country     % source Barclays Plc 3.6 Capital Research & Management Inc. 4.7 Citigroup Inc. 8.4 Deutsche Bank AG 2.5 FMR Corp. (Fidelity Investments) 2.4 Primecap Management Co 9.9 Putnam LLC 2.3 State Street Corp. 2.8 Vanguard Group Inc. 2 Wellington Management Co. 1.9	Brands name items photo compare the prices Avonex Ethishop Biogen Ethishop IDEC Pharmaceuticals Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF BIOGEN_IDEC , group and subsidiaries [click on the images below or on help for more information] 40% Job: 40% of company's jobs cut since 1998 2 Tax haven, secret bank account, shell companies: operates in 2 offshore financial center(s) 367 Top management: earns 367 times the median income in the United States (32000 US$/year) 2 Influence: 2 act(s) of direct corruption or lobbying Full profile >>>
Relevance: business & market share year business source 2006 Biogen Idec is the fifth-largest biotechnology group in the world. Les Echos World locations & Manufacturing country incentive : address & contact : production type source Biogen Investments, Ltd : Biotech Manufacturing Limited : The map of tax haven, secret accounts and shell companies Biogen Idec is managed by year name photo position; compensation source 2002Bucknum, Thomas Vice-president; 2002Kellogg, Peter Chief Financial Officer; 2002Mullen, James Chief Executive Officer; 2002Rastetter, William Chairman; salary: 0.96 million US$; stock-options: 10.78 million US$; 2002Rohn, William Vice-president; salary: 0.65 million US$; stock-options: 10.86 million US$; 1981Gilbert, Walter Chief Executive Officer; Highest paid executives in 2007

Made by year employees <> social impact : country source 2005 -650 Internal restructuring: The group cuts 17% of its workforce to save 200 to 300 million dollars per year.: United States of America Les Echos 2002 995 Layoff plans and labour conditions in 2007 Influence year purpose : intermediary/lobby : institution source 2000 Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate Washington. 1999 Market admission for genetically modified organisms : EuropaBio : : European Commission translate Corporate . Influence in 2007 Financials year   sales income buyback source 2004   12 million shares 2003   0.68 -0.88   billion US$ 2002   0.4 0.15   billion US$ 2001   0.27 0.1   billion US$ 2000   0.15 0.05   billion US$ 1999   4 million shares SmartMoney Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Banco internacional investimentos   No Tax Haven - Saturday 21 June 2008 at 13h02

Banco internacional investimentos   Another offshore bank? - Saturday 21 June 2008 at 13h00

Banco internacional investimentos   Sustainable Bank - Saturday 21 June 2008 at 12h54

Amerada hess   Reverend - Thursday 19 June 2008 at 08h17

Anshan benxi steel group   Sgt. - Thursday 19 June 2008 at 02h04

All comments